AUTX-703
A Phase 1 Study of AUTX-703 in Participants With Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 69 patients (estimated)
- Sponsors
- Auron Therapeutics, Inc.
- Trial Type
- Treatment
- Last Update
- 2 months ago
- SparkCures ID
- 2088
- NCT Identifier
- NCT06846606
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.